Literature DB >> 32123116

Nf1 deletion results in depletion of the Lhx6 transcription factor and a specific loss of parvalbumin+ cortical interneurons.

Kartik Angara1, Emily Ling-Lin Pai2,3,4, Stephanie M Bilinovich1, April M Stafford1, Julie T Nguyen1, Katie X Li1, Anirban Paul5, John L Rubenstein2,3,4, Daniel Vogt6,7.   

Abstract

Neurofibromatosis 1 (NF1) is caused by mutations in the NF1 gene, which encodes the protein, neurofibromin, an inhibitor of Ras activity. Cortical GABAergic interneurons (CINs) are implicated in NF1 pathology, but the cellular and molecular changes to CINs are unknown. We deleted mouse Nf1 from the medial ganglionic eminence, which gives rise to both oligodendrocytes and CINs that express somatostatin and parvalbumin. Nf1 loss led to a persistence of immature oligodendrocytes that prevented later-generated oligodendrocytes from occupying the cortex. Moreover, molecular and cellular properties of parvalbumin (PV)-positive CINs were altered by the loss of Nf1, without changes in somatostatin (SST)-positive CINs. We discovered that loss of Nf1 results in a dose-dependent decrease in Lhx6 expression, the transcription factor necessary to establish SST+ and PV+ CINs, which was rescued by the MEK inhibitor SL327, revealing a mechanism whereby a neurofibromin/Ras/MEK pathway regulates a critical CIN developmental milestone.

Entities:  

Keywords:  MGE; cortical interneuron; oligodendrocyte

Year:  2020        PMID: 32123116      PMCID: PMC7084085          DOI: 10.1073/pnas.1915458117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

1.  Suppressed GABAergic inhibition as a common factor in suspected etiologies of autism.

Authors:  J P Hussman
Journal:  J Autism Dev Disord       Date:  2001-04

Review 2.  Neurofibromatosis type 1: modeling CNS dysfunction.

Authors:  David H Gutmann; Luis F Parada; Alcino J Silva; Nancy Ratner
Journal:  J Neurosci       Date:  2012-10-10       Impact factor: 6.167

3.  Reduced GABAergic Action in the Autistic Brain.

Authors:  Caroline E Robertson; Eva-Maria Ratai; Nancy Kanwisher
Journal:  Curr Biol       Date:  2015-12-17       Impact factor: 10.834

4.  Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1.

Authors:  Rui M Costa; Nikolai B Federov; Jeff H Kogan; Geoffrey G Murphy; Joel Stern; Masuo Ohno; Raju Kucherlapati; Tyler Jacks; Alcino J Silva
Journal:  Nature       Date:  2002-01-16       Impact factor: 49.962

5.  Subpallial Enhancer Transgenic Lines: a Data and Tool Resource to Study Transcriptional Regulation of GABAergic Cell Fate.

Authors:  Shanni N Silberberg; Leila Taher; Susan Lindtner; Magnus Sandberg; Alex S Nord; Daniel Vogt; Gabriel L Mckinsey; Renee Hoch; Kartik Pattabiraman; Dongji Zhang; Jose L Ferran; Aleksandar Rajkovic; Olga Golonzhka; Carol Kim; Hongkui Zeng; Luis Puelles; Axel Visel; John L R Rubenstein
Journal:  Neuron       Date:  2016-10-05       Impact factor: 17.173

6.  Distinct molecular pathways for development of telencephalic interneuron subtypes revealed through analysis of Lhx6 mutants.

Authors:  Yangu Zhao; Pierre Flandin; Jason E Long; Melissa Dela Cuesta; Heiner Westphal; John L R Rubenstein
Journal:  J Comp Neurol       Date:  2008-09-01       Impact factor: 3.215

7.  Apical versus Basal Neurogenesis Directs Cortical Interneuron Subclass Fate.

Authors:  Timothy J Petros; Ronald S Bultje; M Elizabeth Ross; Gord Fishell; Stewart A Anderson
Journal:  Cell Rep       Date:  2015-10-29       Impact factor: 9.423

8.  Hedgehog-dependent oligodendrocyte lineage specification in the telencephalon.

Authors:  N Tekki-Kessaris; R Woodruff; A C Hall; W Gaffield; S Kimura; C D Stiles; D H Rowitch; W D Richardson
Journal:  Development       Date:  2001-07       Impact factor: 6.868

9.  Mafb and c-Maf Have Prenatal Compensatory and Postnatal Antagonistic Roles in Cortical Interneuron Fate and Function.

Authors:  Emily Ling-Lin Pai; Daniel Vogt; Alexandra Clemente-Perez; Gabriel L McKinsey; Frances S Cho; Jia Sheng Hu; Matt Wimer; Anirban Paul; Siavash Fazel Darbandi; Ramon Pla; Tomasz J Nowakowski; Lisa V Goodrich; Jeanne T Paz; John L R Rubenstein
Journal:  Cell Rep       Date:  2019-01-29       Impact factor: 9.423

10.  The LIM homeodomain protein Lhx6 regulates maturation of interneurons and network excitability in the mammalian cortex.

Authors:  Guilherme Neves; Mala M Shah; Petros Liodis; Angeliki Achimastou; Myrto Denaxa; Grant Roalfe; Abdul Sesay; Matthew C Walker; Vassilis Pachnis
Journal:  Cereb Cortex       Date:  2012-06-17       Impact factor: 5.357

View more
  4 in total

1.  Disruption of Critical Period Plasticity in a Mouse Model of Neurofibromatosis Type 1.

Authors:  Mariska van Lier; M Hadi Saiepour; Koen Kole; Juliette E Cheyne; Nawal Zabouri; Thomas Blok; Yi Qin; Emma Ruimschotel; J Alexander Heimel; Christian Lohmann; Christiaan N Levelt
Journal:  J Neurosci       Date:  2020-06-11       Impact factor: 6.167

2.  Hyperactive MEK1 Signaling in Cortical GABAergic Neurons Promotes Embryonic Parvalbumin Neuron Loss and Defects in Behavioral Inhibition.

Authors:  Michael C Holter; Lauren T Hewitt; Kenji J Nishimura; Sara J Knowles; George R Bjorklund; Shiv Shah; Noah R Fry; Katherina P Rees; Tanya A Gupta; Carter W Daniels; Guohui Li; Steven Marsh; David Michael Treiman; Michael Foster Olive; Trent R Anderson; Federico Sanabria; William D Snider; Jason M Newbern
Journal:  Cereb Cortex       Date:  2021-05-10       Impact factor: 5.357

3.  Maf and Mafb control mouse pallial interneuron fate and maturation through neuropsychiatric disease gene regulation.

Authors:  Jin Chen; Siavash Fazel Darbandi; Emily Ling-Lin Pai; Frances S Cho; Jiapei Chen; Susan Lindtner; Julia S Chu; Jeanne T Paz; Daniel Vogt; Mercedes F Paredes; John Lr Rubenstein
Journal:  Elife       Date:  2020-05-26       Impact factor: 8.140

Review 4.  Mechanistic insights from animal models of neurofibromatosis type 1 cognitive impairment.

Authors:  Andrew H Miller; Mary C Halloran
Journal:  Dis Model Mech       Date:  2022-08-29       Impact factor: 5.732

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.